VIVANI MEDICAL INC (VANI)
US92854B1098 - Common Stock
Taking everything into account, VANI scores 2 out of 10 in our fundamental rating. VANI was compared to 187 industry peers in the Health Care Equipment & Supplies industry. The financial health of VANI is average, but there are quite some concerns on its profitability. VANI does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year VANI has reported negative net income.
VANI had a negative operating cash flow in the past year.
VANI had negative earnings in each of the past 5 years.
In the past 5 years VANI always reported negative operating cash flow.
1.2 Ratios
The Return On Assets of VANI (-54.70%) is worse than 68.98% of its industry peers.
VANI has a Return On Equity of -127.98%. This is in the lower half of the industry: VANI underperforms 68.98% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -54.7% | ||
| ROE | -127.98% | ||
| ROIC | N/A |
ROA(3y)-31.92%
ROA(5y)-126.35%
ROE(3y)-55.98%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
VANI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The number of shares outstanding for VANI has been increased compared to 1 year ago.
Compared to 5 years ago, VANI has more shares outstanding
VANI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
Based on the Altman-Z score of -3.53, we must say that VANI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -3.53, VANI is doing worse than 67.38% of the companies in the same industry.
There is no outstanding debt for VANI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.53 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
VANI has a Current Ratio of 3.41. This indicates that VANI is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 3.41, VANI is doing good in the industry, outperforming 61.50% of the companies in the same industry.
VANI has a Quick Ratio of 3.41. This indicates that VANI is financially healthy and has no problem in meeting its short term obligations.
VANI has a better Quick ratio (3.41) than 71.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.41 | ||
| Quick Ratio | 3.41 |
3. Growth
3.1 Past
VANI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.39%, which is quite impressive.
EPS 1Y (TTM)21.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.38%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
VANI is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -10.92% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y19.81%
EPS Next 2Y6.84%
EPS Next 3Y-0.63%
EPS Next 5Y-10.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for VANI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VANI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.84%
EPS Next 3Y-0.63%
5. Dividend
5.1 Amount
No dividends for VANI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
VIVANI MEDICAL INC
NASDAQ:VANI (12/20/2024, 8:00:01 PM)
After market: 1.1897 +0.01 (+0.82%)1.18
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners9.72%
Inst Owner Change-7.82%
Ins Owners15.71%
Ins Owner Change42.78%
Market Cap69.89M
Analysts82.22
Price Target6.12 (418.64%)
Short Float %1.59%
Short Ratio4.35
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.26%
Min EPS beat(2)6.22%
Max EPS beat(2)18.3%
EPS beat(4)4
Avg EPS beat(4)10.61%
Min EPS beat(4)1.96%
Max EPS beat(4)18.3%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-25%
PT rev (3m)-25%
EPS NQ rev (1m)15.38%
EPS NQ rev (3m)15.38%
EPS NY rev (1m)15%
EPS NY rev (3m)15%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.81 | ||
| P/tB | 3.81 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.45
EYN/A
EPS(NY)-0.46
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS0
BVpS0.31
TBVpS0.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -54.7% | ||
| ROE | -127.98% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-31.92%
ROA(5y)-126.35%
ROE(3y)-55.98%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 246.81% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.41 | ||
| Quick Ratio | 3.41 | ||
| Altman-Z | -3.53 |
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)117.41%
Cap/Depr(5y)136.19%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.38%
EPS Next Y19.81%
EPS Next 2Y6.84%
EPS Next 3Y-0.63%
EPS Next 5Y-10.92%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year17.59%
EBIT Next 3Y5.55%
EBIT Next 5Y-26.67%
FCF growth 1Y-19.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.26%
OCF growth 3YN/A
OCF growth 5YN/A